Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.52 -0.27 (-0.92%)
Streaming Delayed Price Updated: 1:54 PM EST, Dec 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t 
Via MarketBeat
Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
From Pfizer Inc.
Via Business Wire
Leiomyosarcoma Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies |Companies – Pfizer, PTC Therapeutics, GlaxoSmithKline, AstraZeneca, Merck
Via AB Newswire
Neuroendocrine Tumor Pipeline Drugs 2023 (Updated), FDA Approvals, Clinical Trials, MOA, ROA | MedImmune, Genentech, Merck & Co, Pfizer, Takeda Oncology, Hutchison MediPharma, and others
Via AB Newswire
Exposures Product Safety
FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
From Pfizer Inc.
Via Business Wire
Pfizer Declares Third-Quarter 2023 Dividend
From Pfizer Inc.
Via Business Wire
Cerebral Aneurysm Treatment Market, Epidemiology, Therapies, FDA Approval, Companies and Market forecast by DelveInsight | Biogen, Pfizer, Roche, Merck, Novartis, Sanofi, Teva Pharmaceutical
Via AB Newswire
Exposures Product Safety
Refractory Acute Myeloid Leukemia Market to witness growth by 2032, estimates DelveInsight | Pfizer, Merck, Novartis, Astellas, Amgen, Janssen, Kartos, Cullinan Oncology, Meryx
Via AB Newswire
Smartsheet Investors’ Hasty Exit Can Be Your Gain
Enterprise workflow collaboration and automation software maker Smartsheet Inc. (NASDAQ: SMAR) shares plummeted over 20% due to its fiscal Q1 2024 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eosinophilic Gastroenteritis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Novartis, Allakos, AstraZeneca, Pfizer, Regeneron, Celgene
Via AB Newswire
Meniere’s Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies|Companies-Otonomy Inc, Solvay Pharmaceuticals, Pfizer, Abbott, Synphora AB
Via AB Newswire
Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval
From Pfizer Inc.
Via Business Wire
Vitiligo Market expected to rise | Companies – Incyte Corporation, Amgen, Boston Pharmaceuticals, Arcutis Biotherapeutics, Pfizer, Dermavant Sciences, Clinuvel Pharmaceuticals, Celgene
Via AB Newswire
Respiratory Syncytial Virus Market expected to rise | Companies – Bavarian Nordic, GlaxoSmithKline, Janssen, Sanofi, AstraZeneca, Moderna, ReViral, Pfizer, expected to drive market
Via AB Newswire
Adeno-Associated Virus (AAV) Vector Based Gene Therapy Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, uniQure, CSL Behring, NightstaRx
Via AB Newswire
Pfizer Invites Public to View and Listen to Webcast of August 1 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
Blepharitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Allergan Plc, Bausch Health , Novartis, Pfizer, AxeroVision
Via AB Newswire
Chronic Kidney Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, Novotech, Vifor Pharma, Takeda, CinCor Pharma, Galderma R&D, Abbott
Via AB Newswire
Atopic Dermatitis Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies, Patient Pool, and Companies DelveInsight | Sanofi, Regeneron, Pfizer, Japan Tobacco, Torii Pharmaceutical
Via AB Newswire
Exposures Product Safety
Alopecia Areata Market Analysis, Growth Opportunities, Clinical Trials Assessment, Emerging Therapies, Leading Companies, and Epidemiology Forecast | Arcutis, Concert Pharmaceutical, HCW Biologics
Via AB Newswire
Biologics and Biosimilars Market Is Touching New Level – A Comprehensive Study with Key Players Amgen, AbbVie, Sanofi-Aventis
Biologics and Biosimilar Market Size, Status and Forecast 2028 
Via SBWire
Topics Intellectual Property
Exposures Intellectual Property
ABSSSI Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Market Forecast by DelveInsight| Merck, Pfizer, Paratek Pharmaceutical, Melinta Therapeutics, Allergan, Novexel
Via AB Newswire
Exposures Product Safety
Complicated Urinary Tract Infection (cUTI) Market to Witness Growth by 2032, Estimates DelveInsight| Meiji Seika Pharma, Pfizer, Novartis, Spero Therapeutics, Tetraphase Pharmaceuticals, Wockhardt
Via AB Newswire
Postherpetic Neuralgia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Pfizer, Winston Laboratories, Xenon Pharma, Bausch Health, Shanghai SIMR
Via AB Newswire
Neuroendocrine Tumors Pipeline, Clinical Trials, and Emerging Drugs (2023) | Companies – MedImmune, Genentech, Merck & Co, Pfizer, Takeda Oncology, Hutchison MediPharma, and Others
Via AB Newswire
Bullish or Bearish? Vetting Animal Health Care Stocks
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up. 
Via MarketBeat
Topics ETFs
Oligodendroglioma Market expected to rise | Companies – EpicentRx, Pfizer, Oblato, Istari Oncology, Bayer, Chimerix, Pfizer, Abbott, expected to drive market
Via AB Newswire
Oncocytoma Market expected to rise | Companies- Pfizer, AstraZeneca, Bristol-Myers Squibb Company, expected to drive market
Via AB Newswire
Ischemic Stroke Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Market Forecast by DelveInsight | Roche, Boehringer Ingelheim, Bayer AG, Pfizer, Biogen, Daiichi Sankyo
Via AB Newswire
Exposures Product Safety
Obesity Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest Drug Approvals, Emerging Drugs, and Growth Prospects | Innovent, Pfizer, Boehringer Ingelheim, Eli Lilly
Via AB Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.